Staged laparoscopic orchiopexy of intra-abdominal testis: Spermatic vessels division versus traction? A multicentric comparative study.

Child Cryptorchidism Laparoscopy Testis Urologic surgical procedures

Journal

Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150

Informations de publication

Date de publication:
19 Jan 2024
Historique:
received: 01 08 2023
revised: 09 01 2024
accepted: 16 01 2024
medline: 4 2 2024
pubmed: 4 2 2024
entrez: 3 2 2024
Statut: aheadofprint

Résumé

Staged laparoscopic management of intra-abdominal testes using pedicular section is recognized as gold standard technique, successful in 85 % of cases for scrotal testicular position with less than 10 % testicular atrophy. Recently, Shehata proposed a new technique without pedicular division for these testes, using spermatic vessels traction, but did not provide a comparative study of the two techniques. To evaluate the laparoscopic spermatic pedicular traction (Shehata technique, ST) for the treatment of intra-abdominal testis, as an alternative to gold standard pedicular section (2-stage Fowler-Stephens, FS). Intra-abdominal testes of 129 patients in two tertiary pediatric urology centers were managed laparoscopically (2011-2019) either by 2-stage FS orchidopexy or ST according to the surgeon preference. Testicular position and size were statistically compared. A total of 147 testes were pulled down by 80 ST and 67 FS, including 18 bilateral cases. Median (IQR) age at surgery was 24.2 (15.6-46.4) months (ST) and 18.3 (13.1-38.2) months (FS) (p = 0.094). Scrotal pulling-down of the testis was performed after a median (IQR) period of 2.3 (1.6-3.4) months (ST) and 6.1 (4.7-8.3) months (FS), respectively (p < 0.005). Although ST had collapsed in 17 cases (21.3 %), only one (1.3 %) redo procedure was required. After a median (IQR) follow-up of 22 (12-40) and 19 (8.75-37) months (p = 0.59), the testis was in the scrotum in 85 % and 81 % of ST and FS cases, respectively (p = 0.51). Testicular atrophy occurred in 10 % of ST and 13.4 % of FS (p = 0.61). Multivariate analysis using the propensity score analysis did not identify any difference between the two techniques. Our results seem to confirm that FS and ST achieve the same results regarding final testicular position and testicular atrophy rate, with a long-term follow-up. Our study supports pediatric surgeons to favor laparoscopic spermatic pedicular traction (ST) which preserves the testicular vascularization and may ensure better spermatogenesis after puberty. More details on the size and position of the testicle at the beginning of the first laparoscopy seem however essential to assess more accurately the outcomes of each surgical technique. Our outcomes will also be re-evaluated when our patients have reached puberty, from an exocrine and endocrine points of view. This study showed similar results after laparoscopic traction or section of spermatic vessels for intra-abdominal testis in a long-term follow-up, providing more evidence for the use of ST as a valuable alternative to FS.

Sections du résumé

BACKGROUND BACKGROUND
Staged laparoscopic management of intra-abdominal testes using pedicular section is recognized as gold standard technique, successful in 85 % of cases for scrotal testicular position with less than 10 % testicular atrophy. Recently, Shehata proposed a new technique without pedicular division for these testes, using spermatic vessels traction, but did not provide a comparative study of the two techniques.
OBJECTIVE OBJECTIVE
To evaluate the laparoscopic spermatic pedicular traction (Shehata technique, ST) for the treatment of intra-abdominal testis, as an alternative to gold standard pedicular section (2-stage Fowler-Stephens, FS).
STUDY DESIGN METHODS
Intra-abdominal testes of 129 patients in two tertiary pediatric urology centers were managed laparoscopically (2011-2019) either by 2-stage FS orchidopexy or ST according to the surgeon preference. Testicular position and size were statistically compared.
RESULTS RESULTS
A total of 147 testes were pulled down by 80 ST and 67 FS, including 18 bilateral cases. Median (IQR) age at surgery was 24.2 (15.6-46.4) months (ST) and 18.3 (13.1-38.2) months (FS) (p = 0.094). Scrotal pulling-down of the testis was performed after a median (IQR) period of 2.3 (1.6-3.4) months (ST) and 6.1 (4.7-8.3) months (FS), respectively (p < 0.005). Although ST had collapsed in 17 cases (21.3 %), only one (1.3 %) redo procedure was required. After a median (IQR) follow-up of 22 (12-40) and 19 (8.75-37) months (p = 0.59), the testis was in the scrotum in 85 % and 81 % of ST and FS cases, respectively (p = 0.51). Testicular atrophy occurred in 10 % of ST and 13.4 % of FS (p = 0.61). Multivariate analysis using the propensity score analysis did not identify any difference between the two techniques.
DISCUSSION CONCLUSIONS
Our results seem to confirm that FS and ST achieve the same results regarding final testicular position and testicular atrophy rate, with a long-term follow-up. Our study supports pediatric surgeons to favor laparoscopic spermatic pedicular traction (ST) which preserves the testicular vascularization and may ensure better spermatogenesis after puberty. More details on the size and position of the testicle at the beginning of the first laparoscopy seem however essential to assess more accurately the outcomes of each surgical technique. Our outcomes will also be re-evaluated when our patients have reached puberty, from an exocrine and endocrine points of view.
CONCLUSIONS CONCLUSIONS
This study showed similar results after laparoscopic traction or section of spermatic vessels for intra-abdominal testis in a long-term follow-up, providing more evidence for the use of ST as a valuable alternative to FS.

Identifiants

pubmed: 38310033
pii: S1477-5131(24)00046-9
doi: 10.1016/j.jpurol.2024.01.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None.

Auteurs

Valeska Bidault-Jourdainne (V)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France. Electronic address: valeska.bidault@chu-lyon.fr.

Nathalie Botto (N)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France; Department of Pediatric Surgery and Urology, Necker Children Hospital, APHP, Paris, France.

Matthieu Peycelon (M)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France; Sorbonne Université, INSERM, Maladies génétiques d'expression pédiatrique, APHP, Hôpital d'Enfants Armand Trousseau, Paris, France; UMR INSERM 1141 NEURODEV, Paris, France.

Elisabeth Carricaburu (E)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France.

Pauline Lopez (P)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France.

Arnaud Bonnard (A)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France.

Thomas Blanc (T)

Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France; Department of Pediatric Surgery and Urology, Necker Children Hospital, APHP, Paris, France.

Alaa El-Ghoneimi (A)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Université Paris Cité, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France.

Annabel Paye-Jaouen (A)

Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Paris, France; Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRESCENDO), Paris, France.

Classifications MeSH